Naturally Splendid Appoints Craig Goodwin as CEO

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,
Published on: Aug 27, 2019

Vancouver, British Columbia – TheNewswire – August 27, 2019 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that company Co-Founder and current President, Mr. J. Craig Goodwin, will resume his role as CEO of Naturally Splendid in addition to maintaining his role as President and a member of the board of directors. Mr. Goodwin replaces Mr. Douglas Mason who resigned as CEO and a director of the Company and its various subsidiaries. Mr. Goodwin was the first CEO of the Naturally Splendid and continued in that role when Naturally Splendid went public in 2013. From that date until 2016, gross sales increased from $113,000 CDN in 2013 to over $6.3M CDN in 2016, being a 5,575% increase over three years. Craig stepped down as CEO at the end of 2016 to focus on establishing distribution channels in multiple territories including Australia, the EU and Asia. In his many years and varied capacities with Naturally Splendid, Craig has been instrumental in raising over $20 million CDN for Naturally Splendid as well as establishing many of the product innovations and business relationships Naturally Splendid currently enjoys. Naturally Splendid CEO Mr. J. Craig Goodwin states, “Naturally Splendid has tremendous opportunities in front of us. We have developed a value chain that will drive revenue in traditional health channels as well as through the emerging infused edibles markets. Additionally, we have diversified our revenue streams to include both Company Branded Products as well revenue as a Contract Manufacturer. It is this foundation that we will leverage to drive shareholder value”. About Naturally Splendid Enterprises Ltd. Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient-dense foods, and related products. Naturally Splendid is focused on the commercial uses of industrial hemp, and once regulations allow, in permitting jurisdictions, this will include CBD (cannabidiol), and other cannabinoid compounds in a broad spectrum of applications. For more information e-mail [email protected] or call Investor Relations at 604-673-9573 On Behalf of the Board of Directors Mr. Craig Goodwin CEO, President, Director Contact Information Naturally Splendid Enterprises Ltd. (NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 465-0548 Fax: (604) 465-1128 E-mail: [email protected] Website: www.naturallysplendid.com Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information. NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Biotechnology Consumer Products and Services Nutraceutical